Fundraising FoxNational Institutes of Health (NIH) — 2017 Investments
268 investments dated 2017 · page 2 of 2 · listed companies and verified rows first · show all
Rapid Dosimetry provides quantitative imaging and absorbed-dose calculation software and services for radiopharmaceutical therapy developers and providers, helping optimize treatment planning, reduce toxicity, and improve patient outcomes.
BiotechDeep TechHealthtechMedical DevicesSaaS
Ramona Optics builds parallelized multi-camera array microscope systems for imaging and analyzing small model organisms and cell cultures in multi-well plates.
BiotechDeep TechHardwareDurham, US
Roarke Horstmeyer(Director)inMark Harfouche(Executive Officer, Director)inRobert Horstmeyer(Director)Margaret Aery(Executive Officer)inGregor Horstmeyer(Executive Officer, Director)
BoardPatrick Weiss(Director)
Co-investorsThe E14 FundARCH Venture Partners
Reveal Pharma develops RVP-001, a manganese-based, gadolinium-free MRI contrast agent designed as a direct replacement for current standard-of-care agents.
BiotechHealthtechMedical Devices
Riptide Bio develops peptide-based therapeutics for cancer and other diseases, leveraging designed lytic peptides with documented activity across multiple disease areas including oncology and infectious disease.
BiotechHealthtechMedical Devices
Charles Garvin(CEO)Dr. L. Edward Clemens(Principal Scientist)Dr. Jesse Jaynes(Principal Scientist)Dr. Clayton Yates(Principal Scientist)
Arrive Health (RxRevu) provides in-workflow software that gives healthcare providers real-time, patient-specific medication coverage and pricing data along with automation for prior authorization, lower-cost alternatives, and patient outreach.
Digital HealthHealthtechSaaSDenver, US
David Carmody Huntress(Executive Officer, Director)Daniel Caron(Executive Officer)Kyle KiserinKevin O'Brien(Executive Officer, Director)
BoardJeffrey Patton(Director)Steve Lindseth(Director)
Co-investorsNat Turner
SafelyYou provides AI-based fall detection and prevention technology for senior living and memory care communities, using video and clinical review to reduce falls, ER visits, and care costs.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
George Netscher(Founder)in
Co-investorsAnorak VenturesATEL VenturesFoundation CapitalPathbreaker VenturesQualcomm VenturesSamsung Next+8 more
IEH provides laboratory testing services for food safety, offering expedited sample analysis and quality assurance to companies across the food industry.
BiotechFoodTech
SciCrunch develops tools and services to improve the quality and reproducibility of scientific literature through research resource identifiers (RRIDs) and open data provisioning.
BiotechData & InfrastructureEdTechSaaSSan Diego, US
Dr. Bandrowski(Founder)Dr. Martone(Founder)BandrowskiMartone
Sciome develops FINS, an AI platform that uses deep learning to automate zebrafish embryo toxicity screening for drug development and regulatory testing.
AI & Machine LearningBiotechDeep TechSaaS
ScitoVation is a contract research organization that assesses chemical compound safety for pharmaceutical, food, agricultural, and consumer product companies using cell-based assays, computational methods, and genetic analysis.
AI & Machine LearningBiotechDeep TechEnterprise SoftwareHealthtechSaaS
SeaTox Research Inc develops bioassays and test kits for detecting marine toxins that contaminate seafood, aiming to use ocean-derived resources to improve health.
BiotechFoodTechHealthtechWilmington, US
Jennifer McCall(Founder)
Co-investorsLifeforce CapitalPfizer Venture InvestmentsDigitalis VenturesLightstone VenturesMorgenthalerRoche Venture Fund+1 more
Securboration develops AI and machine learning solutions for defense and cybersecurity customers, including technology for the Department of Defense and monitoring systems for critical cyber infrastructure.
AI & Machine LearningCybersecurityDefense TechGovTech
BiotechWoburn, US
Daniel R. Jones(Executive Officer, Director, Promoter)inGeorges St. Laurent III(Executive Officer, Director, Promoter)Tisha Jepson(Executive Officer)William St. Laurent(Executive Officer, Director, Promoter)Elizabeth Reczek(Executive Officer)
BoardDouglas Miscoll(Director)
Simergent develops medical device systems for regulated healthcare markets, with expertise in peritoneal dialysis and infusion pump technologies.
BiotechHealthtechMedical DevicesChicago, US
Steve J. Lindo(Co-founder & CEO)inRick Pendergraft(Co-founder & Chief Technology Officer)inDr. James Sloand(Chief Medical Officer)Michael Rohleder(Manager)
Co-investorsAngel Physicians FundPathway BioventuresPlains Ventures
SkinAxis is a biotechnology company that produces genetically engineered 2D and 3D human skin cell models, including keratinocytes, melanocytes, fibroblasts, and reconstituted skin and oral mucosa equivalents, for testing active ingredients and drugs.
BiotechDeep TechHealthtech
HealthtechMountain View, US
Paul Rhodes(Executive Officer, Director)Ray Martino(Director)Paul Grossman(Director)in
Co-investorsTelegraph Hill Partners
Syntr Health Technologies makes the SyntrFuge System, an FDA-cleared device that automates the processing of autologous fat (microfat) for fat grafting, body contouring, and tissue healing.
BiotechHardwareHealthtechMedical DevicesIrvine, US
Ahmed Zobi(Executive Officer, Director)Hugo Salas(Director)Dane Shackleford(Director)
Revr (SynVitro Bio) designs functional proteins by combining AI models with large-scale biophysical data generated from an automated wet lab platform, using a closed-loop process to speed up protein refinement.
AI & Machine LearningBiotechDeep TechHealthtechSan Leandro, US
Zachary Sun(Executive Officer, Director)Michael Nemzek(Executive Officer, Director)Corinna Chen(CEO)
BoardFrancisco Dopazo(Director)in
Co-investorsHumboldt
San Francisco, US
Kacie Neutz(Executive Officer, Director)Matthew L. Raggard(Executive Officer, Director)
BoardStephen Curtis(Director)Ameeth Sankaran(Director)
Thetis is a clinical-stage pharmaceutical company developing TP-317, an oral Resolvin E1 drug that activates the BLT1 receptor to restore tissue and immune balance.
BiotechHealthtechSouthport, US
Frank C Sciavolino(Manager)inGary Mathias(Co-Founder & CEO)inJohn Parkinson(Chief Science Officer)Joyce Steinberg(Chief Medical Officer)
BoardDavid M Wurzer(Manager)Alan Mendelson(Manager)
Co-investorsConnecticut InnovationsFreemind Investments
Tosk is a pharmaceutical company developing therapeutics for oncology, including approaches to reduce treatment-limiting side effects of cancer therapy, drawing on Drosophila-based drug discovery models.
BiotechHealthtechSunnyvale, US
Brian Frenzel(President, CEO, and Director)inOm Srivastava(Executive Vice President, Chief of Technical Operations and Product Development)Stephen Yanofsky(Vice President Research)inCHARLES GARVIN(Director)
BoardHAROLD CROW(Chairman)
Triad Interactive Media provides federal R&D and immersive learning engineering, and offers H-OS, a framework for helping organizations adopt novel technologies like AI, automation, and robotics by addressing workforce friction and driving operational adoption.
AI & Machine LearningEdTechFuture of Work
USDTL provides forensic toxicology testing and drug and alcohol testing services.
BiotechDigital HealthEnterprise SoftwareHealthtech
Douglas Lewis(Founder, President, and Scientific Director)in
Co-investorsNorthlane Capital Partners
Varizymes Diagnostics develops multiplex loop-mediated isothermal amplification (mLAMP) diagnostic kits for point-of-care pathogen detection in human, animal, and aquaculture health applications.
AgTechBiotechDeep TechHealthtechMedical Devices
David Mead(Chief Executive Officer)
VerAvanti develops ultra-small, single-use endoscopic imaging devices using patented scanning fiber technology for minimally invasive procedures.
Deep TechHealthtechMedical DevicesBothell, US
Gerald McMorrow(Founder and CEO)inEric Siebel(Executive Officer)Juan Vegarra(Executive Officer)inLuis Savastano(Executive Officer)inDavid Goesling(Executive Officer)Russell Garrison(Executive Officer, Director)in
VERSA is a consulting and systems integration firm that helps federal, public, and private sector customers transform their IT portfolios through the application of industry-leading tools, technologies, and processes.
Cloud ComputingDeveloper ToolsEnterprise SoftwareSaaSCalverton, US
Kevin Mitchell(Chief Executive Officer & Founder)Michael Maloney(Executive Vice President)E. Glenn Rogers, Sr.(President/COO)Quintus R. Brown(Chief AI Officer)
Transforming the lives of patients through a functional cure for Type 1 Diabetes
BiotechSan Diego, US
Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)Howard Foyt(Executive Officer)inKevin D'Amour(Executive Officer)in
Co-investorsArtis VenturesATEL VenturesBain Capital Life SciencesRA CapitalSanderling VenturesThe Vertical Group+2 more
Vigorous Mind develops cognitive training and brain wellness solutions for older adults and individuals with cognitive difficulties.
AI & Machine LearningDigital HealthHealthtechLongevityRoboticsBoston, US
Yuval Malinsky(CEO)Daphna Malinsky(Director of Cognitive Psychology)
ViVita develops tissue engineering and regenerative medicine products using its patented SPEAR Process, which strips immunological barriers from animal-derived tissues to create immune-compatible biomaterials for human patients.
BiotechHealthtechMedical Devices
VLP Therapeutics develops vaccine treatments and technologies for cancer and infectious diseases including influenza, malaria, and dengue, using its proprietary i-αVLP platform.
BiotechMedical DevicesMaryland, US
Wataru Akahata(Co-Founder, Director, and Chief Executive Officer)Ryuji Ueno(Co-founder)Sachiko Kuno(Co-founder)Jonathan F. Smith(Chief Scientific Officer)
Free and premium website hosting
E-commerceMarketing TechSaaS
Co-investorsColumbia CapitalFelicis VenturesNovak Biddle Venture Partners
Wellth helps individuals with chronic diseases develop positive behavioral habits that improve health outcomes and quality of life.
Digital HealthHealthtech
Matthew Loper(CEO)in
Co-investorsComcast VenturesDistributed VenturesDreamit VenturesEsplanade VenturesFCA Venture PartnersMercato Partners+6 more
WiserSys develops evidence-based prediction tools to assess high-risk human behaviors for use in healthcare, social services, law enforcement, and justice system settings.
AI & Machine LearningDigital HealthHealthtechLegalTechMental HealthBurlington, US
Robert Althoff(Associate Professor of Psychiatry, University of Vermont College of Medicine; Vice Chair of Clinical Affairs, Department of Psychiatry, University of Vermont Medical Center)William Cats-Baril(Associate Professor, University of Vermont Grossman School of Business)Isabelle Desjardins(Associate Professor of Psychiatry, University of Vermont College of Medicine; Chief Medical Officer, University of Vermont Medical Center)Sanchit Maruti(Assistant Professor of Psychiatry, University of Vermont College of Medicine; Attending Inpatient Psychiatrist, University of Vermont Medical Center)
XEME develops therapeutic cancer vaccines leveraging its Aggregon platform and cell-based or tumor protein approaches.
BiotechHealthtechMedical DevicesLombard, US
Sunil S. Metkar(Executive Officer)Marius Teodorescu(Director)Anthony Tate(Executive Officer)Richard J. Robb(Executive Officer)Mircea C. Popescu(Executive Officer, Director)Dorel Nasui(Director)
XGenomes develops genomic sequencing technology using fluorescent probes and machine learning to read genetic and epigenetic information at single-molecule resolution.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBoston, US
Kalim Mir(CEO)inJaney Muñoz(Bio- and Systems Engineer)
Co-investorsFundersClubThink+ Ventures Management, LlcY CombinatorAmino CapitalCantos VenturesFCVC+3 more
-2.png)
Yasa Therapeutics develops PPCM, a nanoscale polymer technology platform designed for contraception and anti-infective applications including viral and bacterial prevention.
BiotechFemTechHealthtechMedical Devices
Mary Weitzel(Co-Founder, CEO, President)Barbara North(Co-founder, Chief Medical Officer)Michael Oldham(Co-Founder, Regulatory Advisor, Pre-clinical development expert)
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(CTO)inNick Damiano(CEO)inJohn Beck(Executive Officer)in
BoardBryan Kim(Director)Robert Weisskoff(Director)inBlayne Roeder(Director)
Co-investorsAstiaCloudStone CapitalDorm RoomF-Prime CapitalShangBay Capital LLCY Combinator+16 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.